Solar Orbiter gets world-first views of the Sun’s poles - European Space Agency
Last Updated:
Thanks to its newly tilted orbit around the Sun, the European Space Agency-led Solar Orbiter spacecr...
Common Antibiotic Found To Tame Blood Pressure in Surprising New Role - SciTechDaily
Last Updated:
Scientists discovered that ciprofloxacin blocks ACE through a novel mechanism, opening new paths for...
Whooping cough cases rise sharply in Washington and Oregon, health officials urge vaccination - KGW
Last Updated:
Health officials warn of whooping cough surge: 1,300+ cases in Washington, 877 in Oregon this year —...
Why is Eric Clapton so roundly disliked among guitarists?
Last Updated:
Simple. It’s fashionable to hate on Clapton. Just like there’s a performative “me too” on hating on...
Stephen A. Smith Responds to Viral Solitaire Photo from NBA Finals Game 4 - Bleacher Report
Last Updated:
ESPN personality Stephen A. Smith took to social media Friday night to explain the viral photo that...
They Finally Opened the Moon – What Scientists Found Inside Changes Everything - The Daily Galaxy
Last Updated:
After decades of mystery and countless scientific hypotheses, we finally have a clear understanding...
Apple’s new iPadOS has given my iPad a new lease of life - Creative Bloq
Last Updated:
There's more laptop in my tablet than ever before.
Australia on the verge of qualification - FIFA
Last Updated:
Top-Rated Biotech Surges On A Bullish Win In Cancer - Investor's Business Daily
Last Updated:
Shares surged Monday after the company said its next-generation cancer drug showed promise in a colo...
Woman on trial for poison mushroom killings says she was trying to fix "bland" meal - CBS News
Last Updated:
Erin Patterson spoke Wednesday about the July 2023 lunch and offered her explanations on how she pla...
What is the experience of wearing a school uniform every day? Do people typically get used to it or dislike it?
Last Updated:
There is always a character difference between the passively accepting and the rights conscious. The...
FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy With or Without Cisplatin Then as a - Merck.com
Last Updated:
Approval introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable l...